Resolving a chronic inflammation mystery

Nature Medicine 23, 914 (2017). doi:10.1038/nm.4384 Authors: Ben Roediger & Wolfgang Weninger Using interleukin (IL)-9-deficient mice, Rauber and colleagues unveil a crucial role for group 2 innate lymphoid cells (ILC2s) in the resolution phase of arthritic inflammation, opening up new therapeutic avenues for chronic inflammatory disease.
Source: Nature Medicine - Category: General Medicine Authors: Tags: News and Views Source Type: research